XML 39 R32.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions |  | 1 Months Ended | 3 Months Ended | 6 Months Ended |
--- | --- | --- | --- | --- | ---
Apr. 04, 2024 | Apr. 30, 2018 | Dec. 31, 2023 | Jun. 30, 2024 | Jul. 31, 2024
Collaboration Agreement [Member] |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Aggregate payment of production facility | $ 135.0 |  |  |  |
Collaboration Agreement [Member] | BiBo Biopharma Engineering Co., Ltd. |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Additional percentage of milestones payment payable upon achievement | $ 61.5 |  |  |  |
Upfront payment |  |  |  | $ 60.0 |
Collaboration Agreement [Member] | BiBo Biopharma Engineering Co., Ltd. | Subsequent Events |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Upfront payment |  |  |  |  | $ 60.0
BiBo Collaboration Agreement [Member] |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Agreement date | Apr. 04, 2024 |  |  |  |
Teva Agreement [Member] |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Nonrefundable upfront payment |  | $ 6.0 |  |  |
Payment upon achievement of certain clinical and commercial milestones |  | 65.0 |  |  |
Asset transfer and license agreement, termination period after written notice |  |  |  | 120 days |
Asset transfer and license agreement, termination period notice of breach |  |  |  | 60 days |
Asset transfer and license agreement termination notice period if bankruptcy petition filed |  |  |  | 60 days |
Milestone payments |  |  | $ 2.5 |  |
Teva Agreement [Member] | Teva's Development Program |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Payment upon achievement of certain clinical and commercial milestones |  | $ 2.5 |  |  |

X
- Definition Additional of milestones payment payable upon achievement. + References No definition available. + Details
Name: | etnb_AdditionalOfMilestonesPaymentPayableUponAchievement
Namespace Prefix: | etnb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Asset transfer and license agreement termination notice period if bankruptcy petition filed. + References No definition available. + Details
Name: | etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled
Namespace Prefix: | etnb_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Asset transfer and license agreement termination period after written notice. + References No definition available. + Details
Name: | etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice
Namespace Prefix: | etnb_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Asset transfer and license agreement termination period notice of failure. + References No definition available. + Details
Name: | etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure
Namespace Prefix: | etnb_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaboration agreement date. + References No definition available. + Details
Name: | etnb_CollaborationAgreementDate
Namespace Prefix: | etnb_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Milestone payment. + References No definition available. + Details
Name: | etnb_MilestonePayment
Namespace Prefix: | etnb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Obligation to payment upon maximum achievement of certain clinical and commercial milestones. + References No definition available. + Details
Name: | etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
Namespace Prefix: | etnb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Production facility payment payables. + References No definition available. + Details
Name: | etnb_ProductionFacilityPaymentPayables
Namespace Prefix: | etnb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Upfront payment. + References No definition available. + Details
Name: | etnb_UpfrontPayment
Namespace Prefix: | etnb_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2 + Details
Name: | us-gaap_AssetAcquisitionConsiderationTransferred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 460 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 450 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9 + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=etnb_CollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=etnb_BiboBiopharmaEngineeringCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=etnb_BiboCollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasDevelopmentProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |